skip to main content

HT-STAR

HT-STAR

Catalogue No.

04072122

Cell Line Name

HT-STAR

Cell Line Description

HT1080 cells serially transfected with synthetic HIV Gag-Pol sequences expressed from a Murine Leukaemia Virus (MLV) vector; HIV tat sequences expressed from a MLV vector and HIV rev sequence expressed from a MLV vector. These cells stably express synthetic HIV Gag-Pol, HIV tat and HIV rev sequences. These cells serve as a packaging cell line for HIV based vectors.

General Info

Species

Human

Release Conditions

Restricted – all customers must complete the specific depositor MTA.

Characteristics

Tissue of Origin

Fibrosarcoma

DNA profile (STR Profile)

Amelogenin: X,Y
CSF1PO: 12
D5S818: 11,13
D7S820: 9,10
D13S317: 12,14
D16S539: 9,12
TH01: 6
TPOX: 8
vWA: 14,19

Karyotype

Not specified

Disease

None Stated

Culture Conditions

Cell Type

Epithelial

Subculture Routine

Split sub-confluent cultures (70-80%) 1:4 to 1:8 i.e. seeding at 1-4x10,000 cells/cm² using 0.05% trypsin or trypsin/EDTA; 10% CO₂; 37°C.

Culture Medium

DMEM + 2mM Glutamine + 10% Foetal Bovine Serum (FBS).

Growth Mode

Adherent

Additional Info

Depositor

Professor Mary Collins, Department of Immunology and Molecular Pathology, University College London

Country of Origin

United Kingdom

GMO Status

Genetically Modified Organism Class 1 (GMO1)

Hazard Group (ACDP)

Hazard Group (ACDP) 2

Applications

References

Ikeda Y et. al., Nat. Biotechnol. (2003) May: 21(5): 569-572

Available Formats

  • Frozen
  • DNA-5µg (100ng/µl)

If use of this culture results in a scientific publication, it should be cited in the publication as: HT-STAR (ECACC 04072122).

Unless specified otherwise, at ECACC we routinely handle all of our cell lines at containment level 2 in accordance with the ACDP guidelines (Advisory Committee on Dangerous Pathogens) (UK). All cell cultures have the potential to carry as yet unidentified adventitious agents. It is the responsibility of the end user to ensure that their facilities comply with biosafety regulations for their own country. ACDP Guidance: Biological agents: Managing the risks in laboratories and healthcare premises.

The Culture Collections represent deposits of cultures from world-wide sources. While every effort is made to ensure details distributed by Culture Collections are accurate, Culture Collections cannot be held responsible for any inaccuracies in the data supplied. References where quoted are mainly attributed to the establishment of the cell culture and not for any specific property of the cell line, therefore further references should be obtained regarding cell culture characteristics. Passage numbers where given act only as a guide and Culture Collections does not guarantee the passage number stated will be the passage number received by the customer.

Cultures supplied by Culture Collections are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.